Traders Buy Large Volume of Call Options on AdaptHealth (NASDAQ:AHCO)

AdaptHealth Corp. (NASDAQ:AHCO) saw some unusual options trading on Wednesday. Stock traders purchased 6,852 call options on the stock. This is an increase of approximately 982% compared to the typical volume of 633 call options.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of AHCO. Iron Triangle Partners LP bought a new position in AdaptHealth during the first quarter valued at $17,496,000. Deerfield Management Company L.P. grew its stake in shares of AdaptHealth by 15.9% during the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock worth $102,726,000 after acquiring an additional 1,572,835 shares during the period. Dimensional Fund Advisors LP increased its holdings in AdaptHealth by 15.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,982,070 shares of the company’s stock worth $53,537,000 after acquiring an additional 809,459 shares during the last quarter. Kennedy Capital Management LLC raised its stake in AdaptHealth by 48.8% in the 3rd quarter. Kennedy Capital Management LLC now owns 2,090,138 shares of the company’s stock valued at $18,707,000 after acquiring an additional 685,554 shares during the period. Finally, CSM Advisors LLC bought a new stake in AdaptHealth in the 2nd quarter valued at about $6,149,000. Institutional investors own 82.67% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AHCO. Zacks Research downgraded AdaptHealth from a “hold” rating to a “strong sell” rating in a research report on Friday, September 19th. Canaccord Genuity Group increased their target price on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Weiss Ratings restated a “hold (c-)” rating on shares of AdaptHealth in a report on Tuesday. Finally, Wall Street Zen downgraded shares of AdaptHealth from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, AdaptHealth currently has an average rating of “Moderate Buy” and an average price target of $13.60.

AdaptHealth Stock Performance

Shares of AHCO stock opened at $9.34 on Thursday. The company has a current ratio of 1.08, a quick ratio of 0.86 and a debt-to-equity ratio of 1.09. The firm has a fifty day simple moving average of $9.30 and a two-hundred day simple moving average of $9.20. AdaptHealth has a 12 month low of $7.11 and a 12 month high of $11.63. The firm has a market capitalization of $1.26 billion, a PE ratio of 16.98, a price-to-earnings-growth ratio of 1.38 and a beta of 1.77.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.24 by ($0.05). The business had revenue of $820.31 million during the quarter, compared to the consensus estimate of $799.62 million. AdaptHealth had a net margin of 2.53% and a return on equity of 4.85%. AdaptHealth’s revenue was up 1.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.15 EPS. Analysts forecast that AdaptHealth will post 0.88 EPS for the current fiscal year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.